openPR Logo
Press release

The NEUROFRIENDS Unveil Debut Album Gone World - A Bold Fusion of Poetry, Music, and AI

06-09-2025 04:48 PM CET | Leisure, Entertainment, Miscellaneous

Press release from: ABNewswire

The NEUROFRIENDS Unveil Debut Album Gone World - A Bold Fusion

An Independent Release Blending Human Emotion with Machine Intelligence - Now Streaming on All Major Platforms
What happens when a poet meets a machine? That question is answered with haunting beauty and cinematic depth on Gone World , the debut album from The NEUROFRIENDS, a groundbreaking new americana music project that merges poetic storytelling with cutting-edge artificial intelligence. Released in May 2025, the album is now available on Spotify, Apple Music, Amazon Music, and all major digital platforms.

Led by poet-songwriter, Mikhail Emelchenkov - the "human part" of the duo - The NEUROFRIENDS project is not your typical AI-assisted endeavor. Rather than relying on automated tools to generate generic tracks, the artist uses a deep knowledge of guitar playing, songwriting, and music editing to shape each piece, treating AI like a palette of sonic colors. The result: a genre-defying soundscape that is both futuristic and deeply personal.

"I see this as a creative revolution," says the project's founder. "Just like photography opened new paths for visual artists, AI gives poets and writers the tools to become music creators, without needing a band, a studio, or a label. Gone World is my proof of concept - and a labor of love."

The album plays like a cinematic journey, with the lyrics front and center. Music serves as a rich, atmospheric backdrop: evoking moods, framing metaphors, and amplifying the emotional weight of each poem-turned-song. The themes are deeply human: isolation, transformation, loss, reinvention. It's a sonic meditation on what it means to create art in a time of machines.

Entirely self-funded and independently produced, Gone World arrives in an era where attention is currency. "I don't expect this release to break even," the artist admits, "but I believe in the message and the possibilities. It's about starting a conversation... about what we gain, what we lose, and what's next for art."

With Gone World , The NEUROFRIENDS join a growing movement of pioneering artists using AI not as a replacement for creativity, but as a collaborator. This project stands apart for its transparency, authenticity, and bold embrace of the future.

Stream Gone World at https://www.youtube.com/playlist?list=OLAK5uy_kHuWj-_ATQ7XW-Ujpi2vODempB3YM49RU

https://www.instagram.com/the_neurofriend [https://www.instagram.com/the_neurofriends]

Media Contact
Company Name: Neurofriends
Contact Person: Mikhail Emelchenkov
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=the-neurofriends-unveil-debut-album-gone-world-a-bold-fusion-of-poetry-music-and-ai]
Country: United States
Website: https://www.instagram.com/the_neurofriends/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The NEUROFRIENDS Unveil Debut Album Gone World - A Bold Fusion of Poetry, Music, and AI here

News-ID: 4057876 • Views:

More Releases from ABNewswire

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the Retinal Vein Occlusion pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Retinal Vein Occlusion pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore

All 5 Releases